Specification and Causal Pathway Diagramming of Implementation Strategies to Support Development of Access‐Enhancing Injectable HIV Treatment Programmes at Eight Diverse Health Clinics Across the United States
Journal of the International AIDS Society · 2026-10 · 29 (S5)
DOI: 10.1002/jia2.70190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International AIDS Society, online erschienen am 08.10.2026. Verfasst von Kathrine Meyers und 23 weiteren Autor:innen. Beteiligte Einrichtung: Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York City, New York, USA. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Rilpivirine, Pyridones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HRSA HHS, Health Resources and Services Administration.
Abstract (Originalsprache)
Introduction
Long‐acting injectable antiretroviral therapy (LAI ART) represents a transformative development in HIV care because it may mitigate longstanding barriers that contribute to gaps in health outcomes. Providing LAI ART to people not consistently on HIV treatment or lacking treatment options requires intentional programme planning to overcome implementation barriers, without which only well‐resourced patients benefit, worsening health outcome gaps. The ALAI UP Project delivered clinic‐level implementation strategies to support eight clinics across Ending the HIV Epidemic jurisdictions to implement injectable cabotegravir and rilpivirine (iCAB/RPV).
Methods
We specified seven implementation strategies and assessed their impact on clinic achievement of three key programme outcomes: (a) access to information about iCAB/RPV for all patients regardless of clinical eligibility; (b) access to iCAB/RPV regardless of healthcare coverage; and (c) access to iCAB/RPV for those who can clinically benefit the most, including patients who are unable to achieve durable viral suppression on oral ART for reasons other than cabotegravir or rilpivirine resistance. Implementation strategies were delivered from March 2023 through February 2025, and results are reported at the end of year 2 of the 3‐year project. We developed causal pathway diagrams (CPDs) for each strategy, identifying determinants, preconditions, moderators, mechanisms and outcomes.
Results
ALAI UP strategies supported clinic progress towards all three outcomes: six clinics had partially or fully achieved access to information about iCAB/RPV for all patients, seven clinics had partially or fully achieved access to iCAB/RPV for patients regardless of healthcare coverage, and six clinics had provided access to iCAB/RPV for those who could benefit the most clinically. By developing CPDs for each strategy, we explicated how strategies operated across different clinical contexts. Through this process, we identified mechanisms of action that needed to be activated, moderators that impacted strategy strength and preconditions that needed to be in place for the strategy to function. These insights informed changes to strategies in the final year of the project.
Conclusion
This work demonstrates that applying implementation science tools to service delivery projects can enhance precision and reproducibility of strategies, identify intervention points for improving strategies when mechanisms are not activated, and clarify hypothesized causal pathways testable in future hybrid effectiveness‐implementation trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York City, New York, USA.
- Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York City, New York, USA.
- Hunter College of the City University of New York, New York City, New York, USA.
- Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA.
- New York City Health Department, Queens, New York, USA.
- Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: Nadia Nguyen, Charlie Ferrusi, Delivette Castor, Bijou R Hunt
Förderung
- HRSA HHS
- Health Resources and Services Administration
Zitieren
APA
Meyers, K., Nguyen, N., Ferrusi, C., Zucker, J., Golub, S. A., Kutner, B. A., Karani, M., Chastain, C. A., Blasingame, M., Brown-Lopez, M., Burdge, J., Castor, D., Carnevale, C., Eldib, J., Furuya, E., Akolo, O., Bastien, K., Curry, M., Holt, W., …, & Matosky, M. (2026). Specification and Causal Pathway Diagramming of Implementation Strategies to Support Development of Access‐Enhancing Injectable HIV Treatment Programmes at Eight Diverse Health Clinics Across the United States. Journal of the International AIDS Society, 29(S5). https://doi.org/10.1002/jia2.70190
Vancouver
Meyers K, Nguyen N, Ferrusi C, Zucker J, Golub SA, Kutner BA, et al. Specification and Causal Pathway Diagramming of Implementation Strategies to Support Development of Access‐Enhancing Injectable HIV Treatment Programmes at Eight Diverse Health Clinics Across the United States. Journal of the International AIDS Society. 2026;29(S5). doi:10.1002/jia2.70190
BibTeX
@article{Meyers2026,
author = {Meyers, Kathrine and Nguyen, Nadia and Ferrusi, Charlie and Zucker, Jason and Golub, Sarit A and Kutner, Bryan A and Karani, Mamta and Chastain, Cody A and Blasingame, Marilyn and Brown-Lopez, Moya and Burdge, Jennifer and Castor, Delivette and Carnevale, Caroline and Eldib, Jenna and Furuya, Elizabeth and Akolo, Omolola and Bastien, Kelly and Curry, Melissa and Holt, Will and Hunt, Bijou R and Ly, Shin and Starks, Carlotta and Torres, Fabriel and Matosky, Marlene},
title = {Specification and Causal Pathway Diagramming of Implementation Strategies to Support Development of Access‐Enhancing Injectable HIV Treatment Programmes at Eight Diverse Health Clinics Across the United States},
journal = {Journal of the International AIDS Society},
year = {2026},
volume = {29},
number = {S5},
doi = {10.1002/jia2.70190}
}
EUVIMED